Fundraising Fox

Cyrano Therapeutics

Washington, US · Founded 2014 · Delaware corporation · 7 employees on LinkedIn · 4 known investors

Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.

Healthtech

Founders & leadership

RG
Richard GeoffrionNamed on SEC filing
RH
Robert HenkinNamed on SEC filing

Board

GBGerry Brunk
Gerry BrunkinBoard Of DirectorsManaging Director at Lumira Ventures
TK
Takahide KodaBoard director

Investors · 4

Remiges Ventures, Inc.Seattle
DeepWork CapitalreportedOrlando
Lumira Venturesreported · 3 sourcesToronto · $1M – $10Mvia Gerry Brunk · board

Also in the syndicate · 1

Florida Opportunity Fundlead

Funding

SEC filings, press & company announcements

$4.1M disclosed across 1 of 4 rounds · 2020–2025

▶$4.1MraisedNov 2020 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GeoffrionExecutive Officer, Director
  • Gerry BrunkDirector
  • Takahide KodaDirector
  • Robert HenkinDirector
Offering amount
$12.8M
Amount sold
$4.1M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Cyrano Therapeutics Raises $9M in Series B Funding to Revolutionize Treatment for Chronic Taste and Smell Lossleadsontrees.com · May 2025Funding for Development of Treatment for Smell loss - Cyrano Therapeuticscyranotherapeutics.com · Feb 2024Cyrano Therapeutics raises $9M Series B round to combat loss of smell - Refresh Miamirefreshmiami.com · Jan 2024Investing in Regenerative Medicine - Cyrano Therapeuticscyranotherapeutics.com · Jul 2022Cyrano Therapeutics Raises $12.8 Million to Complete Phase 2 Trial of CYR-064 for the Restoration of Chronic Smell and Flavor Loss | Markets Insidermarkets.businessinsider.com · Dec 2020

Frequently asked questions

What does Cyrano Therapeutics do?
Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.
Who are Cyrano Therapeutics's investors?
Cyrano Therapeutics's investors include Remiges Ventures, Inc., DeepWork Capital, Lumira Ventures.
How much funding has Cyrano Therapeutics raised?
Cyrano Therapeutics has disclosed $4.1M raised across 1 of its 4 known rounds.
Where is Cyrano Therapeutics headquartered?
Cyrano Therapeutics is headquartered in Washington, US.